BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27414231)

  • 1. Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC).
    Łukaszewicz-Zając M; Szmitkowski M; Litman-Zawadzka A; Mroczko B
    Cancer Invest; 2016 Aug; 34(7):305-12. PubMed ID: 27414231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
    Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
    Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Matrix metalloproteinase in human gastric carcinoma].
    Adachi Y; Itoh F; Imai K
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():107-12. PubMed ID: 11424366
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in invasion of tumours of neuroepithelial tissue].
    Bogaczewicz J; Jasielski P; Mosiewicz A; Trojanowski T; Suchozebrska-Jesionek D; Stryjecka-Zimmer M
    Neurol Neurochir Pol; 2006; 40(5):404-12. PubMed ID: 17103354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer.
    Gao W; Xu J; Wang F; Zhang L; Peng R; Shu Y; Wu J; Tang Q; Zhu Y
    BMC Cancer; 2015 May; 15():367. PubMed ID: 25948494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of metalloproteinases and their inhibitors in pancreatic cancer].
    Łukaszewicz M; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].
    Groblewska M; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2010 Jan; 64():22-30. PubMed ID: 20173217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).
    Lukaszewicz-Zając M; Mroczko B; Kornhuber J; Lewczuk P
    J Neural Transm (Vienna); 2014 May; 121(5):469-77. PubMed ID: 24366530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Matrix metalloproteases as molecular markers in gastric cancer].
    de la Peña S; Sampieri CL; León-Córdoba K
    Med Clin (Barc); 2010 Feb; 134(3):123-6. PubMed ID: 19944435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular aspects of renal desease].
    Nichik TE; Lin'kova NS; Kraskovskaia NA; Dudkov AV; Khavinson VKh
    Usp Fiziol Nauk; 2014; 45(2):49-56. PubMed ID: 25707263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases as modulators of inflammation.
    Manicone AM; McGuire JK
    Semin Cell Dev Biol; 2008 Feb; 19(1):34-41. PubMed ID: 17707664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of metalloproteinases and their inhibitors in gastric cancer].
    Lukaszewicz-Zajac M; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():258-65. PubMed ID: 19502687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer.
    Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and inflammation in cyclosporine A-induced gingival enlargement: a pilot in vitro study using a three-dimensional model of the human oral mucosa.
    Johanson M; Zhao XR; Huynh-Ba G; Villar CC
    J Periodontol; 2013 May; 84(5):634-40. PubMed ID: 22934840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
    Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
    Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
    Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
    Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers.
    Sampieri CL; León-Córdoba K; Remes-Troche JM
    J Cancer Res Ther; 2013; 9(3):356-63. PubMed ID: 24125966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal expression of matrix metalloproteinases and their tissue inhibitors in ulcerative colitis patients.
    Kusugami K; Nobata K; Tsuzuki T; Ando T; Ina K
    J Gastroenterol; 2003; 38(4):412-3. PubMed ID: 12743787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.